Biomedical Seminar Series

“Attacking the Tumor Microenvironment in Drug-Resistant Prostate Cancer” will be presented by Cindy Miranti, Ph.D., professor of Cellular and Molecular Medicine at the University of Arizona, College of Medicine.

The objective of the Miranti Lab is to define how integrin interactions within the tumor microenvironment impact prostate cancer development, hormonal resistance, and metastasis. Their approach is to understand the normal biology of the prostate gland and its microenvironment, as well as the bone environment, to inform on the mechanisms by which tumor cells remodel and use that environment to develop, acquire hormonal resistance, and metastasize. Their research is focused in three primary areas: developing in vitro and in vivo models that recapitulate human disease based on clinical pathology; identifying signal transduction pathway components that could serve as both clinical markers and therapeutic targets; and defining the genetic/epigenetic programming involved in prostate cancer development.

If you are interested in meeting with Dr. Miranti for a one-on-one meeting, please use this sign up here.

For questions, contact Breezy Tottenhoff.